RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 161 filers reported holding RELAY THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,217 | -37.8% | 144,700 | +21.7% | 0.00% | -33.3% |
Q1 2023 | $1,958 | +115.6% | 118,854 | +95.5% | 0.00% | +200.0% |
Q4 2022 | $908 | -99.8% | 60,800 | +134.7% | 0.00% | 0.0% |
Q2 2022 | $434,000 | -47.8% | 25,900 | -6.8% | 0.00% | 0.0% |
Q1 2022 | $832,000 | +287.0% | 27,800 | +297.1% | 0.00% | – |
Q4 2021 | $215,000 | -95.5% | 7,000 | -95.4% | 0.00% | -100.0% |
Q3 2021 | $4,811,000 | – | 152,588 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
Grace Capital | 164,389 | $6,832,000 | 4.32% |
Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |